Trial Profile
Premixed Insulin Aspart 30 (Biasp 30) Vs Premixed Human Insulin 30 (Bhi 30) In Gestational Diabetes Mellitus - A Randomised Controlled Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin
- Indications Gestational diabetes
- Focus Therapeutic Use
- 01 Jul 2012 Results published in the Gynecological Endocrinology.
- 19 Feb 2011 New trial record